BCRX
BioCryst Pharmaceuticals, Inc.When BCRX passed all Ten ChecksBioCryst Pharmaceuticals, Inc.
history · not a forecastOver the past 10 years, BCRX has passed all Ten Checks on 11 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +18.6% in Jul 2018, still rising at session 20.
- Apr 2026+3.1% -10.5%
- Dec 2025+2.9% -13.5%
- Dec 2024+5.4% -8.5%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about BCRX’s checks
How many technical checks does BCRX pass right now?
As of the Aug 26, 2026 close, BCRX passes 6 of 10 fixed technical checks — the checks not passing: market trend rising, not overextended, outperforming the market, adequate stop room.
Why does BCRX fail the "market trend rising" check?
The S&P 500 ($766.08) is below its 10-day average ($768.72), so the market-trend check fails for every stock today, BCRX included. It clears market-wide when the index reclaims $768.72.
What price would change BCRX's check count?
The nearest flip level is "holding above short-term average" fails on a close below $9.76. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.